Skip to main content

Home

Phase Out of Manual Application Submission for Import and Export Licences / Certificates for Pharmaceutical Products and Dangerous Drugs with effect from 31 December 2021

Enhance Regulatory Control of Skin Antiseptic Products

Conditional Approval of Registration of Remdesivir

Special Notices on COVID-19

Special Notice

Regulation of Advanced Therapy Products (Pharmacy and Poisons (Amendment) Bill 2019 has been passed on 17 July 2020)

Enhanced Control of Skin Antiseptics containing Chlorhexidine with effect from July 8, 2020

Requirement of Microbiological Quality of Registered Pharmaceutical Products in Non-sterile Dosage Forms

Requirement of Elemental Impurities Levels/Limits in Registered Pharmaceutical Products

Updates on the Phase 2 Requirement of Bioavailability and Bioequivalence Studies

New information and advice on medicines used for cough and common cold in children

Strengthening the Sales Control of Pharmaceutical Products (i) for Human Parenteral Administration and (ii) containing Designated Vitamins

New medicine labelling requirements to take effect from August 5, 2016

Implementation Plan of Phase 2 Requirement for BABE Studies

Information on Cord Blood & Cell Therapy

New Regulatory Control of Products containing Vitamins and Glucosamine

PIC/S GMP Requirements for Registration of Pharmaceutical Products

New Requirements for Registration of Biosimilar Products

New Application Form and Guidance Notes for Clinical Trial/Medicinal Test Certificate

Enhancement of Database Search for Registered Drugs

Video clips on Safe use of drugs

Be Cautious When Buying Medicines Overseas

Previous

Pause Play

Next

Press Release

Frequently Asked Question

Search Drug Dealers

Search Drug

Products found to contain undeclared medicines

Medicines Recall
Safety Alert




faq